author-photo

Sharrell Lee

Cornell University

23

Papers

1920

Citations

Citation Trend

Filter By

Papers (18) Sort By

Journal Conference Others

Radiation-activated secretory proteins of Scgb1a1 + club cells increase the efficacy of immune checkpoint blockade in lung cancer

2021
Show All
- Source
- Cite
- Save
Citations (1)
Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast Cancer

2020 Cell Reports
Show All
- Source
- Cite
- Save
Citations (22)
Differential contributions of pre- and post- EMT tumor cells in breast cancer metastasis.

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (24)
Immune reprogramming via PD-1 inhibition enhances early-stage lung cancer survival

2018 JCI insight
Show All
- Source
- Cite
- Save
Citations (23)
Abstract 5078: EZH2 methyltransferase regulates disseminating tumor cells in breast cancer metastasis

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Matrix Metalloproteinase 14 promotes lung cancer by cleavage of Heparin-Binding EGF-like Growth Factor

2017 Neoplasia
Show All
- Source
- Cite
- Save
Citations (29)
Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases

2017 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (80)
A phase II study of copper-depletion using tetrathiomolybdate (TM) in patients (pts) with breast cancer (BC) at high risk for recurrence: Updated results.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (5)
Abstract 4447: EZH2 contributes to breast cancer metastasis

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract LB-349: Copper depletion as a strategy to affect the tumor microenvironment in breast cancer patients at high risk of relapse and in triple negative preclinical models of breast cancer: Updated results of a phase II study of tetrathiomolybdate (TM) in breast cancer (BC) patients (pts) at high risk for recurrence

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)